Hendriks, A.E.J.* et al. Clinical care advice for monitoring of islet autoantibody positive individuals with presymptomatic type 1 diabetes. Diabetes Metab. Res. Rev. 40:e3777 (2024)
Herder, C.* et al. Associations between multiple neurological biomarkers and distal sensorimotor polyneuropathy: KORA F4/FF4 study. Diabetes Metab. Res. Rev. 40:e3807 (2024)
Maalmi, H.* et al. Prediction model for polyneuropathy in recent-onset diabetes based on serum neurofilament light chain, fibroblast growth factor-19 and standard anthropometric and clinical variables. Diabetes Metab. Res. Rev. 40:e70009 (2024)
Ziegler, D.* et al. Association of transketolase polymorphisms with diabetic polyneuropathy in the general population: The KORA F4 study. Diabetes Metab. Res. Rev. 40:e3834 (2024)
Askani, E.* et al. Association of MRI-based adrenal gland volume and impaired glucose metabolism in a population-based cohort study. Diabetes Metab. Res. Rev. 38:e3528 (2022)
Dietrich, F.* et al. Immune response differs between intralymphatic or subcutaneous administration of GAD-alum in individuals with recent onset type 1 diabetes. Diabetes Metab. Res. Rev.:e3500 (2022)
Kowall, B.* et al. Associations between haemoglobin A(1c)and mortality rate in the KORA S4 and the Heinz Nixdorf Recall population-based cohort studies. Diabetes Metab. Res. Rev. 37:e3369 (2021)
Niersmann, C.* et al. Omentin-regulated proteins combine a pro-inflammatory phenotype with an anti-inflammatory counterregulation in human adipocytes: A proteomics analysis. Diabetes Metab. Res. Rev. 35:e3074 (2019)
de Las Heras Gala, T. et al. Association of changes in inflammation with variation in glycaemia, insulin resistance and secretion based on the KORA study. Diabetes Metab. Res. Rev. 34:e3063 (2018)
Hartmann, B.* et al. Regional differences in type 2 diabetes treatment and outcomes in Germany-An analysis of the German DPV and DIVE registries. Diabetes Metab. Res. Rev. 34:e3049 (2018)
Herder, C.* et al. Myeloperoxidase, superoxide dismutase-3, cardiometabolic risk factors, and distal sensorimotor polyneuropathy: The KORA F4/FF4 study. Diabetes Metab. Res. Rev. 34:e3000 (2018)
Laaksonen, J.* et al. Blood pathway analyses reveal differences between prediabetic subjects with or without dyslipidaemia. The Cardiovascular Risk in Young Finns Study. Diabetes Metab. Res. Rev. 33:e2914 (2017)
Ziegler, D.* et al. Association of transketolase polymorphisms with measures of polyneuropathy in patients with recently diagnosed diabetes. Diabetes Metab. Res. Rev. 33:e2811 (2017)
Lee, H.S.* et al. Biomarker discovery study design for type 1 diabetes in The Environmental Determinants of Diabetes in the Young (TEDDY) study. Diabetes Metab. Res. Rev. 30, 424-434 (2014)
Orban, E. ; Schwab, S. ; Thorand, B. & Huth, C. Association of iron indices and type 2 diabetes: A meta-analysis of observational studies. Diabetes Metab. Res. Rev. 30, 372-394 (2013)
Raab, J. et al. Continuous rise of insulin resistance before and after the onset of puberty in children at increased risk for type 1 diabetes - a cross-sectional analysis. Diabetes Metab. Res. Rev. 29, 631-635 (2013)
Vehik, K.* et al. Methods, quality control and specimen management in an international multicentre investigation of type 1 diabetes: TEDDY. Diabetes Metab. Res. Rev. 29, 557-567 (2013)
Ziegler, D.* et al. Evaluation of the Neuropad sudomotor function test as a screening tool for polyneuropathy in the elderly population with diabetes and pre-diabetes: The KORA F4 survey. Diabetes Metab. Res. Rev. 28, 692-697 (2012)
Stark, R.G. et al. Medical care of type 2 diabetes in German disease management programmes: A population-based evaluation. Diabetes Metab. Res. Rev. 27, 383-391 (2011)